Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels
about
Dopamine and glucose, obesity, and reward deficiency syndromeGenetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS)Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression.ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers.DNA Methylation Profiling of Human Prefrontal Cortex Neurons in Heroin Users Shows Significant Difference between Genomic Contexts of Hyper- and Hypomethylation and a Younger Epigenetic Age.A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions.Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric.Dopaminergic pathway polymorphisms and heroin addiction: further support for association of CSNK1E variants.Dopamine D1 receptor gene variation modulates opioid dependence risk by affecting transition to addiction.Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans.Glutamatergic and GABAergic susceptibility loci for heroin and cocaine addiction in subjects of African and European ancestryHIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations.Genetics of opiate addiction.Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives.Homers at the Interface between Reward and Pain.Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability.Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls.Biochemical Diagnosis in Substance and Non-substance Addiction.
P2860
Q27003334-2BC1DEBD-7250-433F-9C1D-07B64E0A7B93Q28652508-CBB623AC-3132-4753-9022-92C8C10826D1Q30559281-57DBFA69-CD75-4562-9763-C5122FF23610Q33805049-190089BB-56D5-424D-B5D7-FF472DD617CFQ33836760-C819E447-0C81-492D-8CA6-9FD426D9E299Q34037595-D7A6BA24-853B-4B88-878D-4B0B1250780CQ34304684-BDB09965-C8AD-4180-8120-E0AB3A487CB3Q34891066-A942BAD2-6E00-4F8B-BF56-9D92A87DEB82Q34970338-5F34C43B-FCA7-4009-B4E5-C56E1BC1C2C7Q35439069-C1FD8D85-0192-4FEA-ACD0-17A4B365E9C6Q36042323-4819CD7A-906A-4D6D-BB54-19EE53A2EE3FQ37376944-833B6F32-C211-4CDD-A812-DCCDD6772978Q38248196-0274F6D2-EBEC-4597-850A-E6CB60D68329Q38608450-083BBA77-E46A-4E2F-8BE4-9A154A348866Q42143920-CFFD0C28-1FBC-408F-BA71-6448F5072950Q42630625-FF1F0DD4-7089-46AF-88B2-5F0DCB36F96DQ47360280-423774FC-3065-4621-82E7-59AAA31FA53FQ52314530-0D81E6FA-4D7E-4092-8242-C05D922C7FFA
P2860
Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Dopamine receptor D1 and posts ...... and striatal expression levels
@en
type
label
Dopamine receptor D1 and posts ...... and striatal expression levels
@en
prefLabel
Dopamine receptor D1 and posts ...... and striatal expression levels
@en
P2093
P2860
P356
P1433
P1476
Dopamine receptor D1 and posts ...... and striatal expression levels
@en
P2093
M J Bannon
M M Jacobs
S Morgello
P2860
P2888
P304
P356
10.1038/MP.2012.140
P407
P577
2012-10-09T00:00:00Z